AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 42 min read$FORM

Rhodes Sheri sold $794K of FORM

Rhodes Sheri sold 6,328 shares of FORMFACTOR INC (FORM) at $125.40 ($0.79M total) on 2026-06-02.

Original reporting
SEC EDGAR · Rhodes Sheri
Published Jun 4, 2026, 10:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 4, 2026, 10:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$FORM
Neutral
medium confidence
Mentioned
$FORM
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FORMNeutralLow
01

Why it matters

The disclosure may slightly affect short-term sentiment, but it does not introduce new company fundamentals (no guidance, earnings, deal, or regulatory action).

02

Market read

Use as a minor sentiment/positioning input rather than a standalone trading catalyst.

03

What to watch

The article doesn’t specify whether other insiders are selling/buying, nor does it provide context for the sale size relative to total holdings or compensation.

Relevance 6/10Novelty 6/10Timing: Filed June 4; sale executed June 2 (post-trade disclosure).

Background

SEC Form 4 reports insider transactions (director/officer/10% owners). This filing discloses an open-market sale executed June 2 and reported June 4.

Company-level read

Ticker impact

$FORMNeutralMedium confidence
Context

Director Rhodes Sheri sold $793.5K of FormFactor shares via an open-market transaction disclosed on SEC Form 4.

Expected impact

Low near-term impact; any effect is likely sentiment/flow-driven rather than fundamental.

Evidence & confidence

The filing is a routine insider sale (no 10b5-1 plan stated) with no accompanying operational or financial news.

Market effects

Sector

Minimal; this is company-specific insider activity with no sector-wide read-across stated.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

A single sale can reflect diversification, liquidity needs, or tax planning rather than bearish fundamentals—especially with no stated link to performance.

Key entities

  • issuer
    FORMFACTOR INC

    Company whose director sold shares; subject of the SEC Form 4 insider transaction.

  • insider
    Rhodes Sheri

    Director who executed the open-market sale of FORM shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

FORM insider trading history →

Related articles

OCT 13
$FORMMed

Stifel reiterates FormFactor stock rating after Teradyne deal

Stifel kept a Hold rating and $115 price target on FormFactor (FORM) after Teradyne (TER) agreed to a $300M equity stake, pending approval. FORM shares are down 7.8% this week but up 223% year-over-year. Q2 earnings beat estimates with $0.82 EPS and $258.2M revenue. Deutsche Bank initiated coverage with a Buy rating and $200 target, citing Nvidia and TSMC opportunities.

investing.com2 min
OCT 12
$FORMHighAI 8/10

FormFactor and Teradyne announce collaboration, $300M investment

FormFactor (FORM) and Teradyne (TER) announced a collaboration and $300M investment in semiconductor test and measurement technologies. The deal aims to combine FormFactor's probe technologies with Teradyne's automated test platforms, focusing on high-performance compute and advanced packaging applications. The transaction is subject to regulatory approvals.

investing.com2 min